skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
May 5, 2020 2020 FC 593 Janssen Inc. et al v Teva Canada Limited We successfully represented Janssen in this patent infringement action under the new PMNOC Regulations concerning Janssen’s Invega Sustenna (...

Patents

Jan 2, 2020 2020 FC 1 Seedlings Life Sciences v Pfizer We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’...

Patents

Oct 29, 2019 2019 FC 1355 Janssen Inc. et al v Apotex Inc. We successfully represented Janssen and BTG in this PMNOC application, the last of such proceedings to be heard under the “old” applica...

Patents

Apr 10, 2018 Federal Court File Nos. T-598-17 through T-605-17 AbbVie Corporation et al v Samsung Bioepis Co. Ltd. We represented AbbVie in a series of eight applications under the PMNOC Regulations relating to AbbVie’s blockbuster drug HUMIRA.  The c...

Patents

Apr 9, 2018 Federal Court File No. T-1355-17 Samsung Bioepis Co., Ltd. v AbbVie Biotechnology Ltd. et al. We represented AbbVie in a patent impeachment action brought by Samsung Bioepis in relation to Samsung Bioepis’ biosimilar to AbbVIe’s ...

Patents

Feb 8, 2018 2018 FCA 33 Teva Canada Limited v. Janssen Inc. We successfully represented Janssen on Teva’s appeal from an award of damages and costs in respect of Teva’s infringement of the patent...

Patents

Feb 6, 2018 2018 FCA 32 Apotex Inc. v. Bayer Inc. We successfully represented Bayer Inc. on this appeal, which upheld the patentee’s right to elect its damages.

Patents

Dec 9, 2016 2016 FC 1361 Janssen Inc. et al. v. Actavis Pharma Company et al. We successfully represented Janssen in a patent case relating to the ADHD medication CONCERTA.  The generic company Actavis Pharma had challen...

Patents

Sep 9, 2016 2016 FC 1013 Bayer Inc. v. Apotex Inc. and Cobalt Pharmaceuticals Company We successfully represented Bayer in this patent infringement action. Following a six week trial, the Federal Court agreed that Bayer’s paten...

Patents

May 31, 2016 2016 FCA 161 Pfizer Canada Inc. v. Teva Canada Limited We successfully represented Pfizer in this appeal from an award of section 8 damages in excess of $100 million in relation to a patent on EFFEXOR. ...

Patents

May 31, 2016 2016 FC 593 Janssen Inc. v. Teva Canada Limited We successfully represented Janssen in this action for damages resulting from infringement of the patent covering Janssen’s LEVAQUIN product....

Patents

May 27, 2016 2016 FC 581 Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al. We obtained an order preventing Fresenius from obtaining approval to market a generic version of Bayer’s AVELOX IV product until expiry of Bayer’s patent.  

Patents

Sep 16, 2015 2015 FCA 192 Actavis Pharma Company v. Alcon Canada Inc. We successfully represented Alcon and Bayer in this appeal brought by Actavis. The Federal Court had upheld the validity of Bayer’s patent re...

Patents

Aug 31, 2015 Court File No. T-2247-14 Sanofi-Aventis Canada Inc. v. Eli Lilly Canada Inc. We successfully represented Eli Lilly in a patent proceeding relating to Eli Lilly’s diabetes medicine BASAGLAR. After filing a motion to dis...

Patents

May 4, 2015 2015 FCA 116 Cobalt Pharmaceuticals Company v. Bayer Inc. We successfully represented Bayer in appeals from a decision of the Federal Court regarding patents covering oral contraceptives containing drospir...

Patents

Oct 28, 2014 2014 FCA 242 Janssen Inc. v. Abbvie Corporation We successfully represented Janssen on this appeal from a refusal to grant an amendment to Janssen’s pleading.  The Court of Appeal agre...

Patents

Oct 1, 2014 Court File No. A-45-14 Takeda v. Apotex We represented Takeda on appeals from a section 8 damages action relating to pantoprozole (PANTOLOC®). The appeals were resolved prior to a hea...

Patents

May 14, 2014 2014 FC 462 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company We successfully defended the validity of Bayer’s patent covering the antibiotic moxifloxacin (AVELOX® and VIGAMOX ®) and obtaine...

Patents

May 7, 2014 2014 FC 436 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health We represented Bayer in this application under the PMNOC Regulations. The validity of Bayer’s patent covering the oral contraceptives YASMIN&...

Patents

Apr 3, 2014 2014 FC 248 Teva Canada Limited v. Pfizer Canada Inc. We represented Pfizer in defending a damages case pursuant to section 8 of the PMNOC Regulations.

Patents

Aug 12, 2013 2013 FC 750 Varco Canada Limited v. Pason Systems Corp. Peter Wilcox acted for National Oilwell Varco as lead counsel in a patent infringement and validity trial related to automatic drilling equipment f...

Patents

Mar 11, 2011 2011 FC 239 GlaxoSmithKline Inc. v. Pharmascience Inc. Peter Wilcox successfully acted for GlaxoSmithKline in a proceeding in which attacks on the validity of the patent covering GSK’s diabetes me...

Patents

Jul 12, 2010 2010 FC 741 Nicholas v. Environmental Systems (International) Limited Peter Wilcox acted for Environmental Systems (International) and Reif Estate Wineries at trial in the successful defence of a $27 million copyright...

Copyright

Apr 14, 2010 2010 FC 409 Pfizer Canada Inc. v. Novopharm Limited Peter Wilcox acted for Pfizer in various proceedings relating to pregabalin (LYRICA®).

Patents

Jun 26, 2009 2009 FC 671 Pfizer Canada Inc. v. Apotex Inc. Peter Wilcox acted for Pfizer in a proceeding related to amlodipine (NORVASC®), including successfully resisting a motion to dismiss.

Patents

Nov 6, 2008 2008 SCC 61 Apotex Inc. v. Sanofi-Synthelabo Canada Inc. Peter Wilcox acted for BIOTECanada, an intervener in the Supreme Court of Canada.  BIOTECanada supported the successful respondent Sanofi in t...

Patents

Oct 24, 2008 2008 FC 1195 Lotech Medical Systems Limited v. Kinetic Concepts Inc. Peter Wilcox acted for Kinetic Concepts in a patent infringement and validity action related to therapeutic mattresses.

Patents

Mar 20, 2008 2008 FCA 108 Pfizer Canada Inc. v. Canada (Health) - 2008 FCA 108 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Oct 5, 2007 2007 FC 898 Pfizer Canada Inc. v. Canada (Health) - 2007 FC 898 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Jun 18, 2007 2007 FC 649 Pfizer Canada Inc. v. Canada (Health) - 2007 FC 649 Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (LIPITOR®) against variou...

Patents

Dec 7, 2006 2006 FC 1471 Pfizer Canada Inc. v. Canada (Minister of Health) Peter Wilcox acted for Pfizer in the Federal Court and Federal Court of Appeal in proceedings related to atorvastatin (Lipitor) against various gen...

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy